Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2272348rdf:typepubmed:Citationlld:pubmed
pubmed-article:2272348lifeskim:mentionsumls-concept:C0020663lld:lifeskim
pubmed-article:2272348lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:2272348lifeskim:mentionsumls-concept:C0008328lld:lifeskim
pubmed-article:2272348lifeskim:mentionsumls-concept:C0027893lld:lifeskim
pubmed-article:2272348lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:2272348lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:2272348lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:2272348lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:2272348pubmed:issue1lld:pubmed
pubmed-article:2272348pubmed:dateCreated1991-2-28lld:pubmed
pubmed-article:2272348pubmed:abstractTextNeuropeptide Y (NPY) and cholecystokinin (CCK) are two peptides involved in opposite ways in the control of food intake. A possible interaction between NPY and CCK has not yet been well defined. Two CCK derivatives with agonistic and antagonistic properties were studied with regard to their effects on brain and plasma NPY levels. The CCK agonist decreased NPY levels in plasma and in the hypothalamus but not in the other brain areas assayed. The CCK antagonist reversed the agonist-induced decrease in both plasma and hypothalamus. These results suggest a negative relation between NPY and CCK peptides, which is not surprising given their opposite role in feeding regulation. The hypothalamus, a preferential site of this regulation, appears to be the brain area most involved in the NPY-CCK interaction. The plasma NPY level variations closely reflect the hypothalamic profile, suggesting a direct release of NPY by a mechanism that remains to be investigated.lld:pubmed
pubmed-article:2272348pubmed:languageenglld:pubmed
pubmed-article:2272348pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2272348pubmed:citationSubsetIMlld:pubmed
pubmed-article:2272348pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2272348pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2272348pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2272348pubmed:statusMEDLINElld:pubmed
pubmed-article:2272348pubmed:monthOctlld:pubmed
pubmed-article:2272348pubmed:issn0014-2999lld:pubmed
pubmed-article:2272348pubmed:authorpubmed-author:JacquotCClld:pubmed
pubmed-article:2272348pubmed:authorpubmed-author:BohuonCClld:pubmed
pubmed-article:2272348pubmed:authorpubmed-author:ComoyEElld:pubmed
pubmed-article:2272348pubmed:authorpubmed-author:CohenYYlld:pubmed
pubmed-article:2272348pubmed:authorpubmed-author:MartinezJJlld:pubmed
pubmed-article:2272348pubmed:authorpubmed-author:RodriguezMMlld:pubmed
pubmed-article:2272348pubmed:authorpubmed-author:OroscoMMlld:pubmed
pubmed-article:2272348pubmed:authorpubmed-author:PagesNNlld:pubmed
pubmed-article:2272348pubmed:authorpubmed-author:GourchAAlld:pubmed
pubmed-article:2272348pubmed:issnTypePrintlld:pubmed
pubmed-article:2272348pubmed:day2lld:pubmed
pubmed-article:2272348pubmed:volume187lld:pubmed
pubmed-article:2272348pubmed:ownerNLMlld:pubmed
pubmed-article:2272348pubmed:authorsCompleteYlld:pubmed
pubmed-article:2272348pubmed:pagination117-22lld:pubmed
pubmed-article:2272348pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:2272348pubmed:meshHeadingpubmed-meshheading:2272348-...lld:pubmed
pubmed-article:2272348pubmed:meshHeadingpubmed-meshheading:2272348-...lld:pubmed
pubmed-article:2272348pubmed:meshHeadingpubmed-meshheading:2272348-...lld:pubmed
pubmed-article:2272348pubmed:meshHeadingpubmed-meshheading:2272348-...lld:pubmed
pubmed-article:2272348pubmed:meshHeadingpubmed-meshheading:2272348-...lld:pubmed
pubmed-article:2272348pubmed:meshHeadingpubmed-meshheading:2272348-...lld:pubmed
pubmed-article:2272348pubmed:meshHeadingpubmed-meshheading:2272348-...lld:pubmed
pubmed-article:2272348pubmed:meshHeadingpubmed-meshheading:2272348-...lld:pubmed
pubmed-article:2272348pubmed:meshHeadingpubmed-meshheading:2272348-...lld:pubmed
pubmed-article:2272348pubmed:meshHeadingpubmed-meshheading:2272348-...lld:pubmed
pubmed-article:2272348pubmed:meshHeadingpubmed-meshheading:2272348-...lld:pubmed
pubmed-article:2272348pubmed:year1990lld:pubmed
pubmed-article:2272348pubmed:articleTitleChanges in hypothalamic neuropeptide Y concentrations induced by cholecystokinin analogues.lld:pubmed
pubmed-article:2272348pubmed:affiliationLaboratoire de Pharmacologie, URA-CNRS 594, Faculté de Pharmacie, Chatenay-Malabry, France.lld:pubmed
pubmed-article:2272348pubmed:publicationTypeJournal Articlelld:pubmed